{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:33:49Z","timestamp":1791146029102,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1212\/wnl.48.2.315","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:26:38Z","timestamp":1336915598000},"page":"315-320","source":"Crossref","is-referenced-by-count":113,"title":["HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors"],"prefix":"10.1212","volume":"48","author":[{"given":"E. L.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fridey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Engstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gibble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hansma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Khabbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"9","volume":"117","year":"1992","unstructured":"Gessain A, Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1992;117:933-946.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000110160"},{"key":"e_1_3_1_4_2","first-page":"5","volume":"28","year":"1990","unstructured":"Osame M, Janssen R, Kubota H, et al. Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 1990;28:50-56.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_5_2","first-page":"9","volume":"2","year":"1989","unstructured":"Kramer A, Jacobson S, Reuben JF, et al. Spontaneous lymphocyte proliferation in symptom-free HTLV-I positive Jamaicans. Lancet 1989;2:923-924.","journal-title":"Lancet"},{"key":"e_1_3_1_6_2","unstructured":"Harrison LH Vaz B Taveira DM et al. Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology (in press)."},{"key":"e_1_3_1_7_2","first-page":"2","volume":"152","year":"1990","unstructured":"Dixon PS, Bodner AJ, Okihiro M, et al. Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii. West J Med 1990;152:261-267.","journal-title":"West J Med"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.1.1"},{"key":"e_1_3_1_9_2","first-page":"1","volume":"49","year":"1992","unstructured":"Sheremata WA, Berger JR, Harrington WJ, et al. Human T lymphotropic virus type I-associated myelopathy. Arch Neurol 1992;49:1113-1118.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.30.5"},{"key":"e_1_3_1_11_2","first-page":"8","volume":"6","year":"1993","unstructured":"Jeannel D, Garin B, Kazadi K, et al. The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire. J Acquir Immune Defic Syndr 1993;6:840-844.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.1.4"},{"key":"e_1_3_1_13_2","first-page":"5","volume":"84","year":"1990","unstructured":"Goubau P, Carton H, Kazadi K, Muay KW, Desmyter J. HTLV seroepidemiology in a central African population with high incidence of tropical spastic paraparesis. Trans R Soc Trop Med Hyg 1990;84:577-579.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"e_1_3_1_14_2","first-page":"1","volume":"25","year":"1995","unstructured":"Murphy EL, Wilks R, Morgan OS, et al. Health effects of human T-lymphotropic virus type I in a Jamaican cohort. Int J Epidemiol 1995;25:1090-1097.","journal-title":"Int J Epidemiol"},{"key":"e_1_3_1_15_2","first-page":"3","volume":"49","year":"1989","unstructured":"World Health Organization. Virus Diseases: human T lymphotropic virus type I, HTLV-I. Weekly Epidemiological Record 1989;49:382.","journal-title":"Weekly Epidemiological Record"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.1.1.1"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.1.1"},{"key":"e_1_3_1_18_2","first-page":"7","volume":"341","year":"1993","unstructured":"Murphy EL, Engstrom JW, Miller K, et al. HTLV-II associated myelopathy in 43-year-old woman. Lancet 1993;341:757-758.","journal-title":"Lancet"},{"key":"e_1_3_1_19_2","first-page":"1","volume":"3","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, et al. The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990;3:1096-1101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_3_1_20_2","first-page":"3","volume":"33","year":"1993","unstructured":"Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy\/tropical spastic paraparesis. Ann Neurol 1993;33:392-396.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330103"},{"key":"e_1_3_1_22_2","first-page":"6","volume":"339","year":"1992","unstructured":"Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-646.","journal-title":"Lancet"},{"key":"e_1_3_1_23_2","first-page":"7","volume":"29","year":"1993","unstructured":"Sheremata WA, Harrington WJ, Bradshaw PA, et al. Association of (tropical) ataxic neuropathy with HTLV-II. Virus Res 1993;29:71-77.","journal-title":"Virus Res"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.1"},{"key":"e_1_3_1_25_2","first-page":"3","volume":"255","year":"1986","unstructured":"Robert-Guroff M, Weiss SH, Giron JA, et al. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986;255:3133-3137.","journal-title":"JAMA"},{"key":"e_1_3_1_26_2","first-page":"4","volume":"244","year":"1989","unstructured":"Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989;244:471-475.","journal-title":"Science"},{"key":"e_1_3_1_27_2","first-page":"3","volume":"164","year":"1991","unstructured":"Feigal E, Murphy E, Vranizan K, et al. Human T cell lymphotropic virus type I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis 1991;164:36-42.","journal-title":"J Infect Dis"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410210102"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"Rodgers-Johnson P Morgan OS Mora C et al. The role of HTLV-I in tropical spastic paraparesis in Jamaica. Ann Neurol 1988;23(suppl):S121-S126.","DOI":"10.1002\/ana.410230729"},{"key":"e_1_3_1_30_2","first-page":"3","volume":"322","year":"1990","unstructured":"Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322:383-388.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.1.1"},{"key":"e_1_3_1_32_2","first-page":"2","volume":"87","year":"1988","unstructured":"Kira J, Minato S, Itoyama Y, Goto I, Kato M, Hasuo K. Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data. J Neurol Sci 1988;87:221-232.","journal-title":"J Neurol Sci"},{"key":"e_1_3_1_33_2","first-page":"2","volume":"81","year":"1990","unstructured":"Sasaki S, Komori T, Maruyama S, Takeishi M, Iwasaki Y. An autopsy case of human T lymphotropic virus type I-associated myelopathy (HAM) with a duration of 28 years. Acta Neuropathol (Berl) 1990;81:219-222.","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1992.tb02343.x"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801073180101"},{"key":"e_1_3_1_36_2","unstructured":"Centers for Disease Control. Human T-lymphotropic virus type I screening in volunteer blood donors-United States 1989. MMWR 39;1990:915-924."},{"key":"e_1_3_1_37_2","first-page":"3","volume":"68","year":"1991","unstructured":"Saito M, Kondo A, Kato K, Gotoh M. Bladder dysfunction due to human T-lymphotropic virus type I associated myelopathy. Br J Urol 1991;68:365-368.","journal-title":"Br J Urol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.48.2.315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:02:07Z","timestamp":1711533727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.48.2.315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1212\/WNL.48.2.315"],"URL":"https:\/\/doi.org\/10.1212\/wnl.48.2.315","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}